	US 12,269,815 B2
	Dantrolene prodrugs and methods of their use
Charles Wescott, Woodcliff Lake, NJ (US); Adrian Hepner, Ramsey, NJ (US); and Alyssa Larson, Needham, MA (US)
Assigned to Eagle Research Labs Limited, Qormi (MT)
Filed by EAGLE RESEARCH LABS LIMITED, Qormi (MT)
Filed on May 24, 2022, as Appl. No. 17/751,806.
Application 17/751,806 is a continuation of application No. 16/755,255, granted, now 11,352,347, previously published as PCT/US2018/056713, filed on Oct. 19, 2018.
Claims priority of provisional application 62/674,422, filed on May 21, 2018.
Claims priority of provisional application 62/575,124, filed on Oct. 20, 2017.
Prior Publication US 2022/0324850 A1, Oct. 13, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 405/12 (2006.01); A61K 9/00 (2006.01)

CPC C07D 405/12 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 9/0053 (2013.01)]

18 Claims

1. A ditromethamine salt of the compound of formula I-A